Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.4 HKD | +2.94% | +7.69% | -4.11% |
04-03 | Ascletis Discontinues Trials of FXR Agonist for Biliary Cholangitis, NASH and Hepatitis B Virus | MT |
04-03 | Ascletis Pharma Inc. Announces Strategic Decisions on FXR Agonist ASC42 | CI |